Sai Parenterals shareholders and shareholding pattern
NSE: SAIPARENTBSE: 544742Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹455.65.
27 Oct: open ₹464.70, high ₹481.50, low ₹460.05
- Next results date: the board meets on 1 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,113 Cr1,118th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Apr 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.65
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,07,58852.2% delivered
Sai Parenterals' shareholding pattern for Sep 2026, filed on 16 Oct 2026, with every filing from Mar 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Sai Parenterals, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters51.16%
- Foreign institutions2.85%
- Indian institutions7.84%
- Individuals and others38.15%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| 51.16% | 51.16% | 51.16% | |
| Indian promoters | 51.16% | 51.16% | 51.16% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 48.84% | 48.84% | 48.84% |
| Shares in issue | 4,41,79,231 | 4,41,79,231 | 4,41,79,231 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 3,53,55,991 | 3,22,27,506 | 3,22,27,506 |
| Promoters' shares locked in | 2,26,00,001 | 2,26,00,001 | 2,26,00,001 |
Sai Parenterals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Vijitha Gorrepati, 28.91%. The filing names 7 more members with no shares.
| Holder | |||
|---|---|---|---|
| Vijitha GorrepatiIndividuals and Hindu undivided families | 28.91% | 1,27,73,394 | 100.00% |
| Anil Kumar KarusalaIndividuals and Hindu undivided families | 10.32% | 45,58,597 | 100.00% |
| ARUNA KARUSALAIndividuals and Hindu undivided families | 7.40% | 32,68,010 | 100.00% |
| Kunal KakumanuIndividuals and Hindu undivided families | 4.53% | 20,00,000 | 100.00% |
Largest public holders of Sai Parenterals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| BHASKARA RAO BOLLINENIResident individuals, over ₹2 lakh at face value | 2.90% | 4.56% | 4.56% |
| SAMARSH CAPITAL-SAMARSH CAPITAL-FUND IAlternative investment funds | 3.45% | 3.45% | 3.45% |
| KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD.Insurance companies | 2.89% | 2.35% | 2.35% |
| AIG DIRECT LLCForeign companies | 2.12% | 2.12% | 2.12% |
| AGILIS PARTNERS LLPCompanies | 2.06% | 2.06% | 2.06% |
| KOTAK LIFE SCIENCES FUND IAlternative investment funds | 1.73% | 1.73% | 1.73% |
| NANDA GOVIND BHATTADResident individuals, over ₹2 lakh at face value | 1.66% | 1.66% | 1.66% |
| REINA R JAISINGHANIResident individuals, over ₹2 lakh at face value | 1.59% | 1.59% | 1.59% |
| SAPNA SAMEER SHAHResident individuals, over ₹2 lakh at face value | 1.53% | 1.53% | 1.53% |
| INDIA EMERGING GIANTS FUND LIMITEDForeign portfolio investors, category I | – | 1.33% | 1.33% |
| POOJA LAKSHMI DOPPALAPUDIResident individuals, over ₹2 lakh at face value | – | 1.33% | 1.33% |
| ARIHANT CAPITAL MARKETS LIMITEDCompanies | – | 1.39% | – |
| MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODIForeign portfolio investors, category I | – | 1.17% | – |
| YASHWANT AMRATLAL THAKKARResident individuals, over ₹2 lakh at face value | 1.73% | – | – |
| DOPPALAPUDI POOJA LAKSHMIResident individuals, over ₹2 lakh at face value | 1.33% | – | – |
| ASTORNE CAPITAL VCC - ARVENForeign portfolio investors, category I | 1.15% | – | – |
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODI no longer named, from 1.17%
- Individuals and others: ARIHANT CAPITAL MARKETS LIMITED no longer named, from 1.39%